Is Kezar Life Sciences, Inc. (KZR) a Buy, Sell, or Hold?
NASDAQ : KZR
Kezar Life Sciences, Inc. — Analyst Ratings
$7.29 USD
$0 (0.0%)
- Volume
- 0
- Average Volume
- 87.92K
- Market Capitalization
- $53.86M
- P/E Ratio
- -1.18
- Dividend Yield
- 0.00%
- Price Target
- $7.00
- Year High
- $7.55
- Year Low
- $3.53
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $24.46
Analyst Consensus Summary
Consensus Rating
N/A
7 Analysts
Rating Score
0/5
Recommendation Strength
Upside/Downside
4.1%
vs Current Price
Price Target
$7.00
Average TargetPrice Target Range
Lowest Target
$5.00
45.8% UPSIDE
Average Target
$7.00
Median Estimate
Highest Target
$21.00
-65.3% DOWNSIDEAnalyst Breakdown
Overall Consensus: Hold | Total Analysts: 7
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 2 | 5 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Jefferies | Maury Raycroft | $7 | $4.17 | 2025-10-17 04:50 AM | 67.9% |
| Wells Fargo | Derek Archila | $9 | $6.26 | 2024-12-19 07:20 AM | 43.8% |